Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Blankenberg

Showing results (1-10 of 62) with videos related to

Pageof 7
Sort By:
Zeitschrift Fur Kardiologie|April 16, 2004
[Genet(h)ics: the philosophical concept of the discourse ethics and consequences for the research community]K Witte, S Blankenberg
Der Internist|February 2, 2013
[Personalized therapy in cardiology. Biomarkers, pharmacogenetics and therapy of monogenic diseases]T Eschenhagen, S Blankenberg
Journal of Internal Medicine|April 24, 2018
Biomarkers for heart failure: small molecules with high clinical relevanceC Magnussen, S Blankenberg
Deutsche Medizinische Wochenschrift (1946)|January 22, 2014
[Diagnosis of acute coronary syndrome]R B Schnabel, F Post, S Blankenberg
Zeitschrift Fur Kardiologie|April 16, 2004
[Immunactivation in chronic heart failure. Inflammatory mediators]S Genth-Zotz, S von Haehling, S Blankenberg
Journal of Internal Medicine|May 28, 2019
Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: A translational review of current literatureD Reichart, C Magnussen, T Zeller, et al.
Herz|January 26, 2019
[Troponins as biomarkers for myocardial injury and myocardial infarction]S Blankenberg, T Wittlinger, B Nowak, et al.
Herz|December 1, 2017
Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy?N Fluschnik, P M Becher, R Schnabel, et al.
Herz|May 15, 2001
[The role of inflammation and infection in acute coronary syndrome]S Blankenberg, H J Rupprecht, C Bickel, et al.
Herz|January 22, 2015
[Prevalence and risk factors of atrial fibrillation in Germany : data from the Gutenberg Health Study]R B Schnabel, S S Johannsen, P S Wild, et al.
Pageof 7

Showing results (1-10 of 62) with videos related to

Sort By:
Pageof 7
Zeitschrift Fur Kardiologie|April 16, 2004
[Genet(h)ics: the philosophical concept of the discourse ethics and consequences for the research community]K Witte, S Blankenberg
Der Internist|February 2, 2013
[Personalized therapy in cardiology. Biomarkers, pharmacogenetics and therapy of monogenic diseases]T Eschenhagen, S Blankenberg
Journal of Internal Medicine|April 24, 2018
Biomarkers for heart failure: small molecules with high clinical relevanceC Magnussen, S Blankenberg
Deutsche Medizinische Wochenschrift (1946)|January 22, 2014
[Diagnosis of acute coronary syndrome]R B Schnabel, F Post, S Blankenberg
Zeitschrift Fur Kardiologie|April 16, 2004
[Immunactivation in chronic heart failure. Inflammatory mediators]S Genth-Zotz, S von Haehling, S Blankenberg
Journal of Internal Medicine|May 28, 2019
Dilated cardiomyopathy: from epidemiologic to genetic phenotypes: A translational review of current literatureD Reichart, C Magnussen, T Zeller, et al.
Herz|January 26, 2019
[Troponins as biomarkers for myocardial injury and myocardial infarction]S Blankenberg, T Wittlinger, B Nowak, et al.
Herz|December 1, 2017
Anticoagulation strategies in patients with atrial fibrillation after PCI or with ACS : The end of triple therapy?N Fluschnik, P M Becher, R Schnabel, et al.
Herz|May 15, 2001
[The role of inflammation and infection in acute coronary syndrome]S Blankenberg, H J Rupprecht, C Bickel, et al.
Herz|January 22, 2015
[Prevalence and risk factors of atrial fibrillation in Germany : data from the Gutenberg Health Study]R B Schnabel, S S Johannsen, P S Wild, et al.
Pageof 7